L

Laurence Fayadat‐Dilman

Merck & Co., Inc., Rahway, NJ, USA (United States)

ORCID: 0000-0001-6285-8924

41 papers and 1.1k citations.

PubIndex Score97Top 3% · mid-careerHow it's scored

🌱#8 Emerging Leader in Protein purification and stability

41Publications

1.1kTotal Citations

#8in Protein purification and stability

First publication: 2010First senior author: 2020

Top publicationsby citations

Development of Anti-CD74 Antibody–Drug Conjugates to Target Glucocorticoids to Immune Cells

Philip E. Brandish, Mark Zielstorff, Mark T. Cancilla et al.|Bioconjugate Chemistry|2018

Cited by 58

Indexing the rest of 41 publications…